Rocket Lab (RKLB) Joins Nasdaq-100 Index in June 2026 Rebalance
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.
Rocket Lab's addition to the Nasdaq-100 boosts institutional visibility for the space launch company ahead of the June 2026 index rebalance.
Rocket Lab USA (NASDAQ: RKLB) has been added to the Nasdaq-100 Index as part of the June 2026 rebalance, joining CoreWeave, Astera Labs, Nebius Group, and Teradyne in the index. CNBC's Jim Cramer called the inclusion a 'big deal,' according to Benzinga. Shares fell 7.28% on Friday, June 12, 2026, trading at $106.42, despite the positive index news.
What Changed
- Rocket Lab secured a position in the Nasdaq-100, boosting visibility among institutional investors who track or benchmark against the index, per Benzinga reporting.
- The inclusion takes effect as part of the scheduled June 2026 rebalance, alongside four other companies.
- Wall Street's current consensus stands at 15 Buy and 7 Strong Buy ratings, with no Sell or Strong Sell recommendations as of June 1, 2026.
- A separate SEC 8-K filed June 5, 2026 disclosed a departure or appointment of a director or officer at the company.
Investor Takeaway
Nasdaq-100 inclusion forces index-tracking funds to purchase RKLB shares, structurally expanding the institutional investor base. With 22 Buy-equivalent ratings and no Sell ratings on the Street, analyst sentiment remains constructive heading into the rebalance.
Related Articles
Rocket Lab (NASDAQ: RKLB) Surges 9% on Successful Synspective Launch and Record $2.2B Defence Backlog
KGI Securities Initiates Rocket Lab (RKLB) Coverage With Neutral Rating and $105 Target
Rocket Lab USA (NASDAQ: RKLB) Surges 34% on Record Revenue Milestone
Teradyne (NASDAQ: TER) Joins Nasdaq-100 in Quarterly Rebalance
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.